Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
The American Journal of Cardiology
|
October 15, 1996
Study design and baseline characteristics of the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E: SECURE
E M Lonn, S Yusuf, C I Doris, et al.
American Heart Journal
|
June 30, 2001
Long-term survival in 11,661 patients with multivessel coronary artery disease in the era of stenting: a report from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators
V Dzavik, W A Ghali, C Norris, et al.
Journal of the American College of Cardiology
|
September 14, 2000
Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
J S Hochman, C E Buller, L A Sleeper, et al.
The American Journal of Cardiology
|
May 1, 1994
Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (< 6 weeks) Q-wave acute myocardial infarction (Total Occlusion Post-Myocardial Infarction Intervention Study [TOMIIS]--a pilot study)
V Dzavik, D S Beanlands, R F Davies, et al.
Journal of the American College of Cardiology
|
September 14, 2000
Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock?
J Slater, R J Brown, T A Antonelli, et al.
Journal of the American College of Cardiology
|
September 14, 2000
Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?
V Menon, J G Webb, L D Hillis, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
December 19, 2006
Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning
M R Schmidt, M Smerup, I E Konstantinov, et al.
Journal of the American College of Cardiology
|
September 14, 2000
Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
T A Sanborn, L A Sleeper, E R Bates, et al.
American Heart Journal
|
August 2, 2001
Predictors of improvement in left ventricular function after percutaneous revascularization of occluded coronary arteries: a report from the Total Occlusion Study of Canada (TOSCA)
V Dzavik, R G Carere, G B Mancini, et al.
The Annals of Pharmacotherapy
|
September 24, 1999
Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk
R T Tsuyuki, J A Johnson, K K Teo, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
The American Journal of Cardiology
|
October 15, 1996
Study design and baseline characteristics of the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E: SECURE
E M Lonn, S Yusuf, C I Doris, et al.
American Heart Journal
|
June 30, 2001
Long-term survival in 11,661 patients with multivessel coronary artery disease in the era of stenting: a report from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators
V Dzavik, W A Ghali, C Norris, et al.
Journal of the American College of Cardiology
|
September 14, 2000
Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
J S Hochman, C E Buller, L A Sleeper, et al.
The American Journal of Cardiology
|
May 1, 1994
Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (< 6 weeks) Q-wave acute myocardial infarction (Total Occlusion Post-Myocardial Infarction Intervention Study [TOMIIS]--a pilot study)
V Dzavik, D S Beanlands, R F Davies, et al.
Journal of the American College of Cardiology
|
September 14, 2000
Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock?
J Slater, R J Brown, T A Antonelli, et al.
Journal of the American College of Cardiology
|
September 14, 2000
Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?
V Menon, J G Webb, L D Hillis, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
December 19, 2006
Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning
M R Schmidt, M Smerup, I E Konstantinov, et al.
Journal of the American College of Cardiology
|
September 14, 2000
Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
T A Sanborn, L A Sleeper, E R Bates, et al.
American Heart Journal
|
August 2, 2001
Predictors of improvement in left ventricular function after percutaneous revascularization of occluded coronary arteries: a report from the Total Occlusion Study of Canada (TOSCA)
V Dzavik, R G Carere, G B Mancini, et al.
The Annals of Pharmacotherapy
|
September 24, 1999
Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk
R T Tsuyuki, J A Johnson, K K Teo, et al.
Page
of 4